X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
further section · weitere sektionen (3) 3
adenocarcinoma (1) 1
aged (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
biliary tract neoplasms - drug therapy (1) 1
biliary tract neoplasms - epidemiology (1) 1
biliary tract neoplasms - pathology (1) 1
cancer (1) 1
chemotherapy (1) 1
cholangiocarcinoma (1) 1
cholangiocarcinoma - drug therapy (1) 1
cholangiocarcinoma - epidemiology (1) 1
cholangiocarcinoma - pathology (1) 1
cisplatin (1) 1
clinical trials (1) 1
clinical-trials (1) 1
combination (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - adverse effects (1) 1
deoxycytidine - analogs & derivatives (1) 1
deoxycytidine - therapeutic use (1) 1
disease progression (1) 1
disease-free survival (1) 1
drug therapy, combination (1) 1
erlotinib (1) 1
erlotinib hydrochloride (1) 1
female (1) 1
gall-bladder cancer (1) 1
gallbladder neoplasms - drug therapy (1) 1
gallbladder neoplasms - epidemiology (1) 1
gallbladder neoplasms - pathology (1) 1
gemcitabine (1) 1
hematology, oncology and palliative medicine (1) 1
humans (1) 1
ii trial (1) 1
index medicus (1) 1
male (1) 1
medical colleges (1) 1
middle aged (1) 1
neoplasm metastasis (1) 1
neoplasm staging (1) 1
oncology (1) 1
oncology, experimental (1) 1
organoplatinum compounds - administration & dosage (1) 1
organoplatinum compounds - adverse effects (1) 1
organoplatinum compounds - therapeutic use (1) 1
pancreatic cancer (1) 1
pancreatic-cancer (1) 1
plus gemcitabine (1) 1
quinazolines - administration & dosage (1) 1
quinazolines - adverse effects (1) 1
quinazolines - therapeutic use (1) 1
research (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 181 - 188
Summary Background Combination chemotherapy with gemcitabine and a platinum-based agent is regarded as a standard treatment for patients with advanced... 
Hematology, Oncology and Palliative Medicine | PLUS GEMCITABINE | CHOLANGIOCARCINOMA | CISPLATIN | ONCOLOGY | ADENOCARCINOMA | PANCREATIC-CANCER | CLINICAL-TRIALS | II TRIAL | COMBINATION | CHEMOTHERAPY | GALL-BLADDER CANCER | Erlotinib Hydrochloride | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Deoxycytidine - adverse effects | Female | Quinazolines - administration & dosage | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Gallbladder Neoplasms - epidemiology | Cholangiocarcinoma - epidemiology | Deoxycytidine - administration & dosage | Biliary Tract Neoplasms - epidemiology | Disease Progression | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Aged | Gallbladder Neoplasms - pathology | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Medical colleges | Chemotherapy | Erlotinib | Gemcitabine | Pancreatic cancer | Oncology, Experimental | Clinical trials | Research | Drug therapy, Combination | Cancer | Index Medicus
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 02/2011, Volume 34, Issue 1-2, pp. 71 - 72
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 09/2011, Volume 34, Issue 8-9, pp. 481 - 483
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 09/2011, Volume 34, Issue 8-9, pp. 484 - 486
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.